Cartesian Therapeutics, Inc. earnings per share and revenue

RNAC earnings per share for the last quarter are -1.13 USD whereas the estimation was -0.80 USD which accounts for -40.96% surprise. Company revenue for the same period amounts to 387.00 k USD despite the estimated figure of 1.25 M USD. Estimated earnings per share for the next quarter are -0.83 USD, and revenue is expected to reach 138.00 k USD. Also watch annual changes over time to get a bigger picture of RNAC earnings per share and revenue dynamics.